PROSTATE CANCER NEW DRUG BOOST

Combination therapy found to extend life by 7 months

- MARTIN BAGOT

A NEW drug combination could revolutionise the treatment of advanced prostate cancer and give sufferers months of extra life.

The standard procedure when the disease has spread is to tackle tumors with drugs that block testosterone.

But in advanced and aggressive cases giving a terminal diagnosis, this hormone therapy ceases to be effective.

Scientists added olaparib - which blocks a DNA repair enzyme in cancer cells - to testosterone blocker abiraterone.